Form 4: Colgate-Palmolive Executive Sally Massey Exercises Stock Options and Sells Shares
SEC Form 4 Filing
Sally Massey, Chief Human Resources Officer at Colgate-Palmolive, exercised stock options and sold shares to cover the exercise price and related taxes.
Summary
- On August 6, 2024, Sally Massey, Chief Human Resources Officer of Colgate-Palmolive, exercised stock options for 15,850 shares of common stock at a price of $76.41 per share.
- Simultaneously, Ms. Massey sold 15,850 shares of common stock at a weighted average price of $103.2761 per share, with prices ranging from $103.26 to $103.315.
- The sale of shares was intended to cover the exercise price of the options and related tax withholding.
- Following these transactions, Ms. Massey directly owns 13,942 shares of Colgate-Palmolive common stock and indirectly owns 7,782 shares through the Issuer's 401(k) Plan Trustee.
- She also owns 15,851 stock options.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.
Positives
- The exercise of stock options indicates Ms. Massey's confidence in the company's future performance.
- The sale price of $103.2761 is significantly higher than the exercise price of $76.41, resulting in a profit for Ms. Massey.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be used by investors to gauge management's sentiment about the company's prospects.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The exercise of options and subsequent sale of shares to cover costs is a common practice among executives.
- The specific details of the option grants and vesting schedules are typically outlined in the company's proxy statements.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- The filing provides transparency to shareholders regarding executive compensation and stock ownership.
Key Dates
| Date | Description |
|---|---|
| 09/10/2020 | Grant date of the stock options, which became exercisable in one-third increments beginning on the first anniversary. |
| 08/06/2024 | Date of the stock option exercise and share sale. |
| 08/08/2024 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.